Baidu
map

全面的维生素与人类疾病研究进展汇总

2016-09-22 佚名 生物谷

维生素是维持身体健康所必需的一类有机化合物。这类物质在体内既不是构成身体组织的原料,也不是能量的来源,而是一类调节物质,在物质代谢中其重要作用。这类物质由于体内不能合成或合成量不足,所以虽然需要量很少,但必须经常由食物供给。维生素是个庞大的家族,现阶段所知的维生素就有几十种,大致可分为脂溶性和水溶性两大类。缺乏维生素可能导致多种疾病,本文对过去一段时间关于维生素与人

维生素是维持身体健康所必需的一类有机化合物。这类物质在体内既不是构成身体组织的原料,也不是能量的来源,而是一类调节物质,在物质代谢中其重要作用。这类物质由于体内不能合成或合成量不足,所以虽然需要量很少,但必须经常由食物供给。维生素是个庞大的家族,现阶段所知的维生素就有几十种,大致可分为脂溶性和水溶性两大类。


缺乏维生素可能导致多种疾病,本文对过去一段时间关于维生素与人类疾病的研究进行了盘点。



1.Science:特殊维生素或可阻断器官的老化进程

doi:10.1126/science.aaf2693


一项刊登在Science上的研究论文中,来自瑞士洛桑联邦理工学院(EPFL)等机构的研究人员通过研究揭开了烟酰胺核糖增强机体代谢的奥秘。文章中研究者描述了NR对干细胞功能的正向效应,在很多哺乳动物中,随着年龄增长,特定器官和肌肉组织的再生能力都会下降,而损伤后机体的修复能力同样也会受到影响,这就会引发许多和老化相关的机体障碍。


文章中,研究者给予2岁小鼠(相当于人类的老年阶段)烟酰胺核糖进行治疗,随后他们发现,接受烟酰胺核糖治疗的小鼠机体中的肌肉再生能力明显增强了,而且相比未接受烟酰胺核糖治疗的小鼠而言,接受治疗的小鼠的寿命也延长了。同时研究者进行了一组平行研究,揭示了烟酰胺核糖对大脑和皮肤干细胞的效应,研究者Auwerx说道,本文研究对于再生医学研究领域非常关键,我们讨论的并不是向机体中引入外源性的物质,而是通过在食物中添加特殊物质来恢复机体损伤组织器官的修复能力。


2.Nat Com:补充维生素A为胰腺癌治疗带来希望

doi:10.1038/ncomms12630 


胰腺导管腺癌(PDAC)是最常见的一种胰腺癌类型,这种癌症非常具有侵略性并且难以治疗。许多科学家都在研究促进癌细胞向机体其他部分扩散的基因突变和生化信号途径。最近来自英国的科学家们发现维生素A可以在实验室的细胞模型上帮助对抗这种常见的胰腺癌。


在健康机体中维生素A可以变成全反式维甲酸,发挥调节正常生长和发育等多种功能。当研究人员在实验室的细胞上诱导这一过程,发现全反式维甲酸可以关闭星形细胞用来重塑环境的应力,这会减少纤维化的产生,也会形成一种让胰腺肿瘤的扩散变得更加困难的环境。


不过研究人员提醒大家,这项研究只针对实验室培养的细胞进行了研究,没有证据表明病人补充维生素A可以帮助对抗PDAC。因此还需要进行包括临床试验在内的进一步研究来证实维生素A的抗癌作用。但是他们认为这项研究关于PDAC扩散机制的新观点将帮助科学家发现更多对抗这种疾病可能性。



3.Cancer Cell重大发现 维生素A治疗结肠癌

doi:10.1016/j.ccell.2015.11.001


来自EPFL的科学家们最近发现了一条重要信号通路或可用于对抗结肠癌复发情况。通过维生素A类化合物治疗,将癌症干细胞内一个被关闭的基因重新激活可以帮助清除癌症干细胞并防止发生复发和转移。


研究人员发现维生素A类化合物可以逆转对HOXA5基因表达的阻断,重新激活HOXA5。在结肠癌小鼠模型中,用维生素A类化合物进行治疗可以阻断癌症进展,使组织正常化,除此之外还可以清除癌症干细胞,并防止癌细胞转移的发生。研究人员在病人样本中也发现了类似的效果。


4.Neurology:摄入维生素D或可帮助改善多发性硬化症患者的病情

doi:10.1212/WNL.0000000000002316


刊登在国际杂志Neurology上的一篇研究报告中,来自约翰霍普金斯大学的研究人员通过研究发现,摄入高剂量的维生素D3或许对多发性硬化症患者是安全的,而且可以帮助调节机体中过度活化的免疫反应。


研究人员Peter Calabresi博士指出,这些研究结果让我们非常激动,维生素D是一种治疗多发性硬化症的非常廉价、安全且有效的疗法,而我们也需要开展更多的研究来在大量人群中证实,同时也可以帮助我们理解这些效应发生的机制。血液中低水平的维生素D和个体患多发性硬化症的风险增加直接相关,而多发性硬化症患者如果机体维生素D水平较低就很有可能患上残疾或者多种疾病。


5.JCO:维生素D缺乏预测前列腺癌

doi:10.1200/JCO.2015.65.1463


一项发表于国际杂志Journal of Clinical Oncology上的研究论文中,来自美国西北大学Feinberg医学院等机构的科学家揭示了低水平维生素D和恶性前列腺癌的关系,研究者发现,男性机体血液中维生素D水平降低或可帮助预测个体的恶性前列腺癌的发生。


研究者Adam Murphy说道,维生素D缺乏或可作为一种生物标志物来预测恶性前列腺癌,深色皮肤、较低维生素D摄入或较少晒太阳的男性个体当被诊断为前列腺癌或PSA水平较高时,就应当进行维生素D缺乏的检测,而维生素D的缺失或许可以通过补充剂的摄入来改善。此前研究揭示了维生素D水平和恶性前列腺癌的关联,本文研究中研究者又揭示了二者之间更加直接的关系,这种特殊关联或可帮助解释不同前列腺癌患者之间的机体差异情况,尤其是非洲裔美国个体;研究者此前发现,相比高加索人而言,生活在低日光照射区域的非洲裔美国男性发生维生素D缺乏的可能性是前者的1.5倍。


6.柳叶刀子刊:孕期补充维生素D有助冬季出生宝宝骨骼发育

DOI: http://dx.doi.org/10.1016/S2213-8587(16)00044-9


南安普顿大学的一项最新研究表明孕期补充维生素D或许可以增强冬季出生宝宝的骨骼发育。这项研究共招募了超过1000名孕妇进行孕期补充维生素D的随机双盲安慰剂对照试验。


参与研究的女性随机分组从妊娠14周开始到宝宝出生每天服用1000单位(25毫克)维生素D或对应剂量的安慰剂。研究结果表明上述剂量的维生素D能够有效增加母亲体内的维生素D水平,孕晚期(大部分钙矿物质从母亲转移到宝宝的时间点)的检测结果表明,补充了维生素D的孕妇中有超过80%的人达到了预期水平,而安慰剂组只有35%达到标准。


随后研究人员对所有出生的宝宝进行了分析,发现母亲补充了维生素D的宝宝与母亲服用安慰剂的宝宝在骨量上没有显著差异。但是进一步根据宝宝出生时间进行分析发现,母亲补充了维生素D并且出生在冬天的宝宝其骨量高于母亲服用安慰剂也出生在冬天的宝宝。


这项研究表明母亲在孕期补充维生素D能够弥补因季节变化导致的维生素D水平下降,这或许可以保证冬天出生宝宝能有更好的骨骼发育。


7.Nat Commun:科学家发现抗衰老关键,维生素B3能延缓衰老


西班牙国家癌症研究中心(CNIO)的科学家们与Valencia大学的科学家、马德里IMDEA合作,提高整体的细胞抗氧能力,而不是仅仅集中抗氧化酶。为了达到抗氧化能力的整体提高,研究人员聚焦于提高NADPH的水平。


研究人员利用基因手段提高的NADPH含量,他们使用了转基因小鼠,此小鼠在整个体内高水平表达产生NADPH最重要的酶—葡萄糖-6-磷酸脱氢酶。研究结果在Nature Communications上发表,结果表明增加G6PD酶,从而增加NADPH增强了机体的自然抗氧化能力,防止氧化损伤,减少了衰老相关过程,例如胰岛素抵抗,并延长了寿命。


维他命B3与其衍生物对NADPH前体合成其重要作用,适合作为今后研究的候选药物。


8.Ophthalmology:维生素C可以延缓女性白内障进展


眼睛里面的液体富含维生素C,可以防止晶状体氧化,预防其变浑浊,所以增加维生素C摄入量,是否就能增加眼内液体的维生素C含量,进而对白内障的进展起保护性作用。研究称,富含维生素C的饮食可潜在的预防白内障进展。


研究者对324对女性双胞胎进行随访,分别通过眼底检查和问卷调查获取参与者晶状体浑浊和饮食中维生素C摄入情况。研究数据显示,维生素C摄入更高的人群,白内障进展风险可降低33%(相比低摄入人群),而维生素C摄入较少的群体,10年后晶状体浑浊度较高(相比高摄入人群)。


研究的第一作者Kate Yonova-Doing说:“人本身不能产生维生素C,所以体内的来源依靠饮食。目前我们没有发现维生素补充剂能多么显著的降低风险,所以健康饮食将优于维生素补充剂。”


9.维生素D或可改善心力衰竭患者的心脏功能


来自英国利兹大学的研究人员通过开展一项为期5年的研究计划发现,每日摄入一定剂量的维生素D3或可改善慢性心力衰竭患者的心脏功能。


研究者Klaus Witte说道,这项研究对于心力衰竭的患者非常重要,本文研究结果表明,维生素D3可以改善心脏肌无力患者的心脏功能;机体中维生素D3的水平可以通过晒太阳来提高,但心力衰竭患者却不能通过这种方式来增强维生素D3的水平,甚至在夏天也是如此,相比年轻人而言,老年人晒太阳后并不能制造较高水平的维生素D3,而皮肤中维生素D3的产生通常会因涂抹防晒霜而明显降低。


研究者指出,本文研究他们发现摄入一定剂量的维生素D3可改善慢性心力衰竭患者的心脏功能,对于后期基于此开发新型疗法来改善心力衰竭患者的机体健康提供了新的线索和希望。


10.PLoS ONE :提高维生素D水平可有效预防癌症的发生


有研究显示增加人体血液中维生素D的含量可能成为一种预防癌症的重要手段,因为他们的研究发现随着维生素D水平的下降,癌症的发生率将大大提高。PLos One杂志中,来自加州大学 - 圣地亚哥分校(UCSD)医学院的研究人员报道了他们是如何分析维生素D与癌症的联系,以确定什么样的血液维生素D水平对有效降低患癌症风险是必需的。


研究人员发现,临床研究组(维生素D的中位数水平较低)的癌症发病率为每10万人1020例,比前瞻性研究组,其癌症发病率为每10万人722例要高。他们还发现,癌症发病率随着25-羟基维生素D水平的上涨而下降;维生素D水平为40 ng/ml或更高的妇女比维生素D水平为20ng/ml或更低的妇女患癌症的风险低67%。


研究人员并没有提维生素D的最佳摄入量应该是多少,或者应该如何促进维生素D的合成,如是否应该通过多晒太阳,或改变补充饮食结构来增加维生素D的合成。


11.PNAS:维生素C或可增加AML标准疗法的疗效

doi:10.1073/pnas.1612262113 


来自美国南加州大学、温安德尔研究所(Van Andel Research Institute)和丹麦哥本哈根大学国王医院(Rigshospitalet)等机构的研究人员在实验室研究中证实在癌细胞系中,往一种被称作地西他滨(decitabine)的表观遗传抗癌药物中添加一种维生素C会增加这种药物阻止癌细胞生长和触发癌细胞自我摧毁的能力。


在丹麦哥本哈根大学国王医院(Rigshospitalet)里,基于这项研究的一项临床预试验正在患有MDS或AML的成年病人体内开展。它将一种类似的被称作阿扎胞苷(azacitidine)的药物---标准的治疗方法---与维生素C组合在一起。很多癌症病人缺乏维生素C;建议的方法就是弥补这种缺乏,但不应让病人体内的维生素C水平超标。


这种类型的组合疗法是大有希望的,但是还需开展更多的研究来确定它的安全性和有效性。


纯干货!盘点各种维生素及功能


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2070397, encodeId=6f5020e0397c0, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Sat Feb 04 01:17:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138720, encodeId=4e08138e206e, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:30:04 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138719, encodeId=89b5138e190d, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:29:57 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137014, encodeId=23e613e014ba, content=学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72061947345, createdName=1e106614m27(暂无匿称), createdTime=Wed Sep 28 15:01:11 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134298, encodeId=083413429830, content=继续学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160911/IMG57D533019D7149622.jpg, createdBy=6f861949824, createdName=1e10f683m35(暂无匿称), createdTime=Sat Sep 24 11:21:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380564, encodeId=90661380564bf, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Sat Sep 24 00:17:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133202, encodeId=cee51332020d, content=维生素是维持身体健康所必需的一类有机化合物, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133203, encodeId=06d613320329, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133073, encodeId=4df91330e3d7, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133074, encodeId=8c721330e46b, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2070397, encodeId=6f5020e0397c0, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Sat Feb 04 01:17:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138720, encodeId=4e08138e206e, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:30:04 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138719, encodeId=89b5138e190d, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:29:57 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137014, encodeId=23e613e014ba, content=学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72061947345, createdName=1e106614m27(暂无匿称), createdTime=Wed Sep 28 15:01:11 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134298, encodeId=083413429830, content=继续学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160911/IMG57D533019D7149622.jpg, createdBy=6f861949824, createdName=1e10f683m35(暂无匿称), createdTime=Sat Sep 24 11:21:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380564, encodeId=90661380564bf, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Sat Sep 24 00:17:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133202, encodeId=cee51332020d, content=维生素是维持身体健康所必需的一类有机化合物, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133203, encodeId=06d613320329, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133073, encodeId=4df91330e3d7, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133074, encodeId=8c721330e46b, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=)]
    2016-10-01 doctorJiangchao

    继续关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2070397, encodeId=6f5020e0397c0, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Sat Feb 04 01:17:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138720, encodeId=4e08138e206e, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:30:04 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138719, encodeId=89b5138e190d, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:29:57 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137014, encodeId=23e613e014ba, content=学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72061947345, createdName=1e106614m27(暂无匿称), createdTime=Wed Sep 28 15:01:11 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134298, encodeId=083413429830, content=继续学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160911/IMG57D533019D7149622.jpg, createdBy=6f861949824, createdName=1e10f683m35(暂无匿称), createdTime=Sat Sep 24 11:21:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380564, encodeId=90661380564bf, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Sat Sep 24 00:17:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133202, encodeId=cee51332020d, content=维生素是维持身体健康所必需的一类有机化合物, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133203, encodeId=06d613320329, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133073, encodeId=4df91330e3d7, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133074, encodeId=8c721330e46b, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=)]
    2016-10-01 doctorJiangchao

    继续学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2070397, encodeId=6f5020e0397c0, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Sat Feb 04 01:17:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138720, encodeId=4e08138e206e, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:30:04 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138719, encodeId=89b5138e190d, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:29:57 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137014, encodeId=23e613e014ba, content=学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72061947345, createdName=1e106614m27(暂无匿称), createdTime=Wed Sep 28 15:01:11 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134298, encodeId=083413429830, content=继续学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160911/IMG57D533019D7149622.jpg, createdBy=6f861949824, createdName=1e10f683m35(暂无匿称), createdTime=Sat Sep 24 11:21:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380564, encodeId=90661380564bf, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Sat Sep 24 00:17:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133202, encodeId=cee51332020d, content=维生素是维持身体健康所必需的一类有机化合物, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133203, encodeId=06d613320329, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133073, encodeId=4df91330e3d7, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133074, encodeId=8c721330e46b, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=)]
    2016-09-28 1e106614m27(暂无匿称)

    学习?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2070397, encodeId=6f5020e0397c0, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Sat Feb 04 01:17:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138720, encodeId=4e08138e206e, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:30:04 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138719, encodeId=89b5138e190d, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:29:57 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137014, encodeId=23e613e014ba, content=学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72061947345, createdName=1e106614m27(暂无匿称), createdTime=Wed Sep 28 15:01:11 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134298, encodeId=083413429830, content=继续学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160911/IMG57D533019D7149622.jpg, createdBy=6f861949824, createdName=1e10f683m35(暂无匿称), createdTime=Sat Sep 24 11:21:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380564, encodeId=90661380564bf, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Sat Sep 24 00:17:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133202, encodeId=cee51332020d, content=维生素是维持身体健康所必需的一类有机化合物, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133203, encodeId=06d613320329, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133073, encodeId=4df91330e3d7, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133074, encodeId=8c721330e46b, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=)]
    2016-09-24 1e10f683m35(暂无匿称)

    继续学习?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2070397, encodeId=6f5020e0397c0, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Sat Feb 04 01:17:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138720, encodeId=4e08138e206e, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:30:04 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138719, encodeId=89b5138e190d, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:29:57 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137014, encodeId=23e613e014ba, content=学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72061947345, createdName=1e106614m27(暂无匿称), createdTime=Wed Sep 28 15:01:11 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134298, encodeId=083413429830, content=继续学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160911/IMG57D533019D7149622.jpg, createdBy=6f861949824, createdName=1e10f683m35(暂无匿称), createdTime=Sat Sep 24 11:21:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380564, encodeId=90661380564bf, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Sat Sep 24 00:17:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133202, encodeId=cee51332020d, content=维生素是维持身体健康所必需的一类有机化合物, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133203, encodeId=06d613320329, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133073, encodeId=4df91330e3d7, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133074, encodeId=8c721330e46b, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2070397, encodeId=6f5020e0397c0, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Sat Feb 04 01:17:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138720, encodeId=4e08138e206e, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:30:04 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138719, encodeId=89b5138e190d, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:29:57 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137014, encodeId=23e613e014ba, content=学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72061947345, createdName=1e106614m27(暂无匿称), createdTime=Wed Sep 28 15:01:11 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134298, encodeId=083413429830, content=继续学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160911/IMG57D533019D7149622.jpg, createdBy=6f861949824, createdName=1e10f683m35(暂无匿称), createdTime=Sat Sep 24 11:21:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380564, encodeId=90661380564bf, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Sat Sep 24 00:17:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133202, encodeId=cee51332020d, content=维生素是维持身体健康所必需的一类有机化合物, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133203, encodeId=06d613320329, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133073, encodeId=4df91330e3d7, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133074, encodeId=8c721330e46b, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=)]
    2016-09-22 医路开来

    维生素是维持身体健康所必需的一类有机化合物

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2070397, encodeId=6f5020e0397c0, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Sat Feb 04 01:17:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138720, encodeId=4e08138e206e, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:30:04 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138719, encodeId=89b5138e190d, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:29:57 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137014, encodeId=23e613e014ba, content=学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72061947345, createdName=1e106614m27(暂无匿称), createdTime=Wed Sep 28 15:01:11 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134298, encodeId=083413429830, content=继续学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160911/IMG57D533019D7149622.jpg, createdBy=6f861949824, createdName=1e10f683m35(暂无匿称), createdTime=Sat Sep 24 11:21:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380564, encodeId=90661380564bf, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Sat Sep 24 00:17:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133202, encodeId=cee51332020d, content=维生素是维持身体健康所必需的一类有机化合物, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133203, encodeId=06d613320329, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133073, encodeId=4df91330e3d7, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133074, encodeId=8c721330e46b, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=)]
    2016-09-22 医路开来

    学习啦,,,

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2070397, encodeId=6f5020e0397c0, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Sat Feb 04 01:17:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138720, encodeId=4e08138e206e, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:30:04 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138719, encodeId=89b5138e190d, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:29:57 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137014, encodeId=23e613e014ba, content=学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72061947345, createdName=1e106614m27(暂无匿称), createdTime=Wed Sep 28 15:01:11 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134298, encodeId=083413429830, content=继续学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160911/IMG57D533019D7149622.jpg, createdBy=6f861949824, createdName=1e10f683m35(暂无匿称), createdTime=Sat Sep 24 11:21:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380564, encodeId=90661380564bf, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Sat Sep 24 00:17:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133202, encodeId=cee51332020d, content=维生素是维持身体健康所必需的一类有机化合物, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133203, encodeId=06d613320329, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133073, encodeId=4df91330e3d7, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133074, encodeId=8c721330e46b, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=)]
    2016-09-22 doctorJiangchao

    继续学习

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2070397, encodeId=6f5020e0397c0, content=<a href='/topic/show?id=f30de0713e1' target=_blank style='color:#2F92EE;'>#疾病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70713, encryptionId=f30de0713e1, topicName=疾病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=010d202, createdName=amy0550, createdTime=Sat Feb 04 01:17:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138720, encodeId=4e08138e206e, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:30:04 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138719, encodeId=89b5138e190d, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Oct 01 21:29:57 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137014, encodeId=23e613e014ba, content=学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72061947345, createdName=1e106614m27(暂无匿称), createdTime=Wed Sep 28 15:01:11 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134298, encodeId=083413429830, content=继续学习?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160911/IMG57D533019D7149622.jpg, createdBy=6f861949824, createdName=1e10f683m35(暂无匿称), createdTime=Sat Sep 24 11:21:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380564, encodeId=90661380564bf, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Sat Sep 24 00:17:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133202, encodeId=cee51332020d, content=维生素是维持身体健康所必需的一类有机化合物, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133203, encodeId=06d613320329, content=学习啦,,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Thu Sep 22 18:44:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133073, encodeId=4df91330e3d7, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=133074, encodeId=8c721330e46b, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Sep 22 14:02:00 CST 2016, time=2016-09-22, status=1, ipAttribution=)]
    2016-09-22 doctorJiangchao

    继续关注

    0

相关资讯

科普:生物素的7大好处惊叹到你!

生物素是水溶性维生素,帮助机体将食物转化为能量,对孕妇和哺乳期女性尤为重要。此外,生物素对维系头发、皮肤和指甲健康至关重要。这篇文章将带领你深入探究生物素的奥秘和对机体的益处。生物素是什么? 生物素是维生素B,也被称为维生素B7。它曾被称为辅酶R和维生素H。它有许多重要的功能,对维持羧化酶(参与机体代谢)功能的正常发挥至关重要。生物素的推荐摄入量是婴儿5微克/天,成年人30微克/天。哺乳期女性35

2016AuSPEN指南:肠外营养成人维生素补充发布

2016年3月,澳大利亚肠外和肠内营养学会(AuSPEN)发布了肠外营养成人维生素补充指南,维生素是肠外营养的重要组成部分,应为所有接受PN的患者提供维生素。除了推荐的每年监测维生素D外,常规监测维生素含量,对接受常规复合维生素制剂的患者未必是必须的。当评估、开处方以及监测接受PN的患者时,临床评估是个重要的因素。有待进一步研究的领域也已经确定。获取全文:下载地址:指南下载(需要扣积分2分,&nb

诺奖得主沃森:维生素片不仅无益,反而致癌,是个残酷骗局

导语:主流医学界已经对“维生素热”有了明确的结论:健康成人服用维生素补充剂不但无益甚至有害。而面对国内仍旧疯涨的维生素补充剂和保健品市场,也是时候给它降降温了。▲最近几年,将维生素补充剂当作保健品成了国人追逐健康的重要手段。但在地球另一端,欧美学界最近正掀起一股“讨伐”维生素保健品的热潮。诺奖得主沃森就曾在《新科学家》上撰文称,认为很多研究显示服用大剂量的维生素反会升高癌症和糖尿病风险。1 欧

如何啪啪啪,怀孕几率会增加?

关于如何怀孕,一直有很多传言,比如“啪啪啪之后腰和屁股下面垫枕头“、”某个姿势啪啪啪有利于怀孕“、”泡澡洗桑拿不容易怀孕“,还有“女性高潮更容易受孕”等等,这些传言到底靠谱不?在第二届东方妇产科学论坛的“妇科内分泌分论坛”上,就职于美国凯撒医疗集团、美国妇产科学会会员侯璟玟博士发表了“如何将自然怀孕的几率最大化”的主题演讲,为大家详细讲解了影响自然受孕几率的因素——看看都有哪些?

Nutr J:产前补充VitD3对宝宝免疫反应有什么影响?

产前补充维生素D3(VitD3)可显著增加孕产妇和新生儿的5羟维生素D3(25(OH)D3)浓度,但母胎维生素D状态的改善对新生儿免疫反应的作用尚不清楚。 为了探讨产前补充VitD3对脐血T细胞功能的影响,研究来纳入了健康的孟加拉孕妇(n = 160),随机接受口服35000 IU/周vitD3或安慰剂(从孕26-29周,到分娩)。在参与者的一个子集(n = 80  )中,对脐带血单个核细胞

科学合理应用女性健康检测助力实现优生优育

近日,在上海举办的“2016罗氏妇女健康专家研讨会”上,北京大学人民医院生殖医学中心主任沈浣教授、上海仁济医院生殖中心主任洪燕副教授、北京协和医院产科主任医师高劲松教授等妇科领域知名专家就女性健康相关检测的国内外最新进展及临床应用进行了深入讨论。 沈浣教授指出:“随着生殖医学的迅速发展,女性健康检测方法与项目也在不断丰富与完善。其中,孕前及妊娠期检测在评估女性生育能力及孕期风险方面发挥

Baidu
map
Baidu
map
Baidu
map